{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:15:58Z","timestamp":1786979758647,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00204-025-03995-4","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:30:45Z","timestamp":1740749445000},"page":"2023-2038","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic activation and cytotoxicity of ibudilast mediated by CYP3A4"],"prefix":"10.1007","volume":"99","author":[{"given":"Lingwen","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xialing","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-2147","authenticated-orcid":false,"given":"Jiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"3","key":"3995_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0378-4274(95)80011-2","volume":"76","author":"S Al Casey","year":"1995","unstructured":"Al Casey S, Brewster D, Viau C, Acosta D (1995) Effect of glutathione depletion and oxidative stress on the in vitro cytotoxicity of velnacrine maleate. Toxicol Lett 76(3):257\u2013265. https:\/\/doi.org\/10.1016\/0378-4274(95)80011-2","journal-title":"Toxicol Lett"},{"issue":"7","key":"3995_CR2","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1517\/13543784.16.7.935","volume":"16","author":"MRH Annemarie Ledeboer","year":"2007","unstructured":"Annemarie Ledeboer MRH, Watkins LR, Johnson KW (2007) Ibudilast (AV-411): a new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes Central & Peripheral Nervous Systems. Expert Opin Investig Drug 16(7):935\u2013950. https:\/\/doi.org\/10.1517\/13543784.16.7.935","journal-title":"Expert Opin Investig Drug"},{"issue":"3","key":"3995_CR3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1248\/cpb.40.639","volume":"40","author":"K Awano","year":"1992","unstructured":"Awano K, Iwase K, Nagatsu Y, Suzue S (1992) Synthesis of metabolites and related compounds of 3-Isobutyryl-2-isopropylpyrazolo (1, 5-a) pyridine (Ibudilast). II. metabolites of pyridine ring. Chem Pharm Bull 40(3):639\u2013643. https:\/\/doi.org\/10.1248\/cpb.40.639","journal-title":"Chem Pharm Bull"},{"issue":"13","key":"3995_CR4","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1056\/NEJM199503303321307","volume":"332","author":"PJ Barnes","year":"1995","unstructured":"Barnes PJ (1995) Inhaled glucocorticoids for asthma. N Engl J Med 332(13):868\u2013875. https:\/\/doi.org\/10.1056\/NEJM199503303321307","journal-title":"N Engl J Med"},{"issue":"3","key":"3995_CR5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/978-3-7091-7539-2_8","volume":"7","author":"PJ Barnes","year":"1994","unstructured":"Barnes PJ, Pauwels RA (1994) Theophylline in the management of asthma: time for reappraisal\u202f? Eur Respir J 7(3):579\u2013591. https:\/\/doi.org\/10.1007\/978-3-7091-7539-2_8","journal-title":"Eur Respir J"},{"issue":"4","key":"3995_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s40733-016-0029-3","volume":"9","author":"PJ Barnes","year":"1996","unstructured":"Barnes PJ, Jonsson B, Klim JB (1996) The costs of asthma. Eur Respir J 9(4):636\u2013642. https:\/\/doi.org\/10.1186\/s40733-016-0029-3","journal-title":"Eur Respir J"},{"issue":"Suppl 66","key":"3995_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1034\/j.1398-9995.56.s66.2.x","volume":"56","author":"H Bisgaard","year":"2001","unstructured":"Bisgaard H (2001) Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma. Allergy 56(Suppl 66):7\u201311. https:\/\/doi.org\/10.1034\/j.1398-9995.56.s66.2.x","journal-title":"Allergy"},{"issue":"3","key":"3995_CR8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1021\/acs.chemrestox.1c00396","volume":"35","author":"Z Ding","year":"2022","unstructured":"Ding Z, Wang X, Zhang N, Sun C, Zhao G, Peng Y, Zheng J (2022) Metabolic activation of perampanel mediated by CYP1A2. Chem Res Toxicol 35(3):490\u2013498. https:\/\/doi.org\/10.1021\/acs.chemrestox.1c00396","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"3995_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejphar.2006.02.053","volume":"538","author":"LCD Gibson","year":"2006","unstructured":"Gibson LCD, Hastings SF, McPhee I, Clayton RA, Darroch CE, Mackenzie A, MacKenzie FL, Nagasawa M, Stevens PA, MacKenzie SJ (2006) The inhibitory profile of ibudilast against the human phosphodiesterase enzyme family. Eur J Pharmacol 538(1):39\u201342. https:\/\/doi.org\/10.1016\/j.ejphar.2006.02.053","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"3995_CR10","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/jat.3277","volume":"36","author":"MJ G\u00f3mez-Lech\u00f3n","year":"2016","unstructured":"G\u00f3mez-Lech\u00f3n MJ, Tolosa L, Donato MT (2016) Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs. J Appl Toxicol 36(6):752\u2013768. https:\/\/doi.org\/10.1002\/jat.3277","journal-title":"J Appl Toxicol"},{"issue":"4","key":"3995_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.01247-2017","volume":"52","author":"R Gosens","year":"2018","unstructured":"Gosens R, Gross N (2018) The mode of action of anticholinergics in asthma. Eur Respir J 52(4):1\u201311. https:\/\/doi.org\/10.1183\/13993003.01247-2017","journal-title":"Eur Respir J"},{"issue":"1","key":"3995_CR12","doi-asserted-by":"publisher","first-page":"E101","DOI":"10.1208\/aapsj080112","volume":"8","author":"FP Guengerich","year":"2006","unstructured":"Guengerich FP (2006) Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J 8(1):E101-111. https:\/\/doi.org\/10.1208\/aapsj080112","journal-title":"AAPS J"},{"issue":"3","key":"3995_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cld.2007.06.001","volume":"11","author":"BK Gunawan","year":"2007","unstructured":"Gunawan BK, Kaplowitz N (2007) Mechanisms of drug-induced liver disease. Clin Liver Dis 11(3):459\u2013475. https:\/\/doi.org\/10.1016\/j.cld.2007.06.001","journal-title":"Clin Liver Dis"},{"issue":"3","key":"3995_CR14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1089\/neu.2011.1863","volume":"29","author":"AT Hama","year":"2012","unstructured":"Hama AT, Broadhead A, Lorrain DS, Sagen J (2012) The antinociceptive effect of the asthma drug ibudilast in rat models of peripheral and central neuropathic pain. J Neurotrauma 29(3):600\u2013610. https:\/\/doi.org\/10.1089\/neu.2011.1863","journal-title":"J Neurotrauma"},{"issue":"4","key":"3995_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/02770909209048938","volume":"29","author":"A Kawasaki","year":"1992","unstructured":"Kawasaki A, Hoshino K, Osaki R, Mizushima Y, Yano S (1992) Effect of ibudilast: a novel antiasthmatic agent, on airway hypersensitivity in bronchial asthma. J Asthma 29(4):245\u2013252. https:\/\/doi.org\/10.3109\/02770909209048938","journal-title":"J Asthma"},{"issue":"14","key":"3995_CR16","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.phymed.2011.06.026","volume":"18","author":"NH Kim","year":"2011","unstructured":"Kim NH, Jung HY, Cho SY, Park SU, Park JM, Ko CN (2011) Liver enzyme abnormalities during concurrent use of herbal and conventional medicines in Korea: a retrospective study. Phytomedicine 18(14):1208\u20131213. https:\/\/doi.org\/10.1016\/j.phymed.2011.06.026","journal-title":"Phytomedicine"},{"issue":"1","key":"3995_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mayocp.2013.09.016","volume":"89","author":"MD Leise","year":"2014","unstructured":"Leise MD, Poterucha JJ, Talwalkar JA (2014) Drug-induced liver injury. Mayo Clin Proc 89(1):95\u2013106. https:\/\/doi.org\/10.1016\/j.mayocp.2013.09.016","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"3995_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3109\/03602532.2011.605791","volume":"44","author":"L Leung","year":"2012","unstructured":"Leung L, Kalgutkar AS, Obach RS (2012) Metabolic activation in drug-induced liver injury. Drug Metab Rev 44(1):18\u201333. https:\/\/doi.org\/10.3109\/03602532.2011.605791","journal-title":"Drug Metab Rev"},{"issue":"404","key":"3995_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2024.12.009","volume":"8","author":"S Liu","year":"2025","unstructured":"Liu S, Zhao G, Xu Y, Wang Y, Ding Z, Li W, Peng Y, Zheng J (2025) Metabolic activation and hepatic cytotoxicity of osthole mediated by cytochrome P450 enzymes. Toxicol Lett 8(404):1\u20138. https:\/\/doi.org\/10.1016\/j.toxlet.2024.12.009","journal-title":"Toxicol Lett"},{"issue":"1","key":"3995_CR20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S0022-5347(24)07209-4","volume":"1","author":"JR Mitchell","year":"1973","unstructured":"Mitchell JR, Jollow DJ, Gillette JR, Broidi BB (1973) Drug Metabolism as a cause of drug toxicity. Drug Metab Dispos 1(1):418\u2013423","journal-title":"Drug Metab Dispos"},{"issue":"1\u20132","key":"3995_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mrfmmm.2009.09.005","volume":"690","author":"JR Murdoch","year":"2010","unstructured":"Murdoch JR, Lloyd CM (2010) Chronic inflammation and asthma. Mutat Res-Fund Mol M 690(1\u20132):24\u201339. https:\/\/doi.org\/10.1016\/j.mrfmmm.2009.09.005","journal-title":"Mutat Res-Fund Mol M"},{"issue":"20","key":"3995_CR22","doi-asserted-by":"publisher","first-page":"11397","DOI":"10.1021\/acs.jmedchem.0c00524","volume":"63","author":"BH Norman","year":"2020","unstructured":"Norman BH (2020) Drug induced liver injury (DILI). Mechanisms and medicinal chemistry avoidance\/mitigation strategies. J Med Chem 63(20):11397\u201311419. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00524","journal-title":"J Med Chem"},{"issue":"6","key":"3995_CR23","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/j.1365-2125.2008.03270.x","volume":"66","author":"P Rolan","year":"2008","unstructured":"Rolan P, Gibbons JA, He L, Chang E, Jones D, Gross MI, Davidson JB, Sanftner LM, Johnson KW (2008) Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses. Br J Clin Pharmacol 66(6):792\u2013801. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03270.x","journal-title":"Br J Clin Pharmacol"},{"issue":"17","key":"3995_CR24","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1517\/14656560903426189","volume":"10","author":"P Rolan","year":"2009","unstructured":"Rolan P, Hutchinson MR, Johnson KW (2009) Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease. Drug Eval 10(17):2897\u20132904. https:\/\/doi.org\/10.1517\/14656560903426189","journal-title":"Drug Eval"},{"issue":"12","key":"3995_CR25","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3109\/00498250903254340","volume":"39","author":"LM Sanftner","year":"2009","unstructured":"Sanftner LM, Gibbons JA, Gross MI, Suzuki BM, Gaeta FC, Johnson KW (2009) Cross-species comparisons of the pharmacokinetics of ibudilast. Xenobiotica 39(12):964\u2013977. https:\/\/doi.org\/10.3109\/00498250903254340","journal-title":"Xenobiotica"},{"issue":"2","key":"3995_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.rmed.2004.07.003","volume":"99","author":"MR Sears","year":"2005","unstructured":"Sears MR, Lotvall J (2005) Past, present and future\u2014\u03b22-adrenoceptor agonists in asthma management. Resp Med 99(2):152\u2013170. https:\/\/doi.org\/10.1016\/j.rmed.2004.07.003","journal-title":"Resp Med"},{"issue":"64","key":"3995_CR27","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.3791\/3917","volume":"29","author":"L Shen","year":"2012","unstructured":"Shen L, Hillebrand A, Wang DQ, Liu M (2012) Isolation and primary culture of rat hepatic cells. J vis Exp 29(64):3917. https:\/\/doi.org\/10.3791\/3917","journal-title":"J vis Exp"},{"issue":"9","key":"3995_CR28","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1021\/tx200168d","volume":"24","author":"AF Stepan","year":"2011","unstructured":"Stepan AF, Walker DP, Bauman J, Price DA, Baillie TA, Kalgutkar AS, Aleo MD (2011) Structural alert\/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem Res Toxicol 24(9):1345\u20131410. https:\/\/doi.org\/10.1021\/tx200168d","journal-title":"Chem Res Toxicol"},{"issue":"12","key":"3995_CR29","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1021\/acs.chemrestox.6b00275","volume":"29","author":"H Wang","year":"2016","unstructured":"Wang H, Feng Y, Wang Q, Guo X, Huang W, Peng Y, Zheng J (2016) Cysteine-based protein adduction by epoxide-derived metabolite(s) of benzbromarone. Chem Res Toxicol 29(12):2145\u20132152. https:\/\/doi.org\/10.1021\/acs.chemrestox.6b00275","journal-title":"Chem Res Toxicol"},{"issue":"12","key":"3995_CR30","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1124\/dmd.117.077818","volume":"45","author":"H Wang","year":"2017","unstructured":"Wang H, Peng Y, Zhang T, Lan Q, Zhao H, Wang W, Zhao Y, Wang X, Pang J, Wang S, Zheng J (2017) Metabolic epoxidation is a critical step for the development of benzbromarone-induced hepatotoxicity. Drug Metab Dispos 45(12):1354\u20131363. https:\/\/doi.org\/10.1124\/dmd.117.077818","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"3995_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5688\/aj710598","volume":"71","author":"MM Zdanowicz","year":"2007","unstructured":"Zdanowicz MM (2007) Pharmacotherapy of asthma. Am J Pharm Educ 71(5):98. https:\/\/doi.org\/10.5688\/aj710598","journal-title":"Am J Pharm Educ"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-03995-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-03995-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-03995-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T03:49:35Z","timestamp":1747453775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-03995-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3995"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-03995-4","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}